Activity Description
The webcast is comprised of the proceedings from the satellite symposium held at Heart Rhythm 2015, Stroke Prevention in Atrial Fibrillation: Advancements in LAA Closure and Novel Oral Anticoagulation Therapy.
Enjoy this web-based version of the symposium, which captures the live cases, lectures, debates, and interactive panel discussions from the symposium in HD video.
Access Webcast
Access Webcast
Click on the session title listed below to view each presentation.
Welcome and Opening RemarksVivek Reddy |
|
|
Session I - AF-Related Stroke & AnticoagulationModerators: Daniel Singer and John Camm |
||
|
Stroke vs Bleeding in AF: Using Risk Scores in Clinical Practice Jeremy Ruskin |
Peri-procedural Management of NOACs Luigi Di Biase |
|
|
Atrial Scarring & LAA Morphology: The Future of Risk Stratification? Nassir Marrouche |
Device-Detected Atrial High Rate Episodes: Risk and Management John Camm |
|
|
Selecting the Right NOAC for the Right Patient Daniel Singer |
Management of Cryptogenic Stroke: ILRs and Anticoagulation Carlos Morillo |
|
|
Overcoming a Barrier to the Novel Anticoagulants: Development of Antidotes Michael Ezekowitz |
||
|
Jeremy Ruskin, Nassir Marrouche, Carlos Morillo, Michael Ezekowitz, |
||
Session II - WatchmanModerator: Vivek Reddy |
||
|
Watchman Implantation: Tips and Tricks Shephal Doshi |
||
Watchman Implantation – Case 1Broadcast from Mount Sinai Hospital |
||
Session III - Amplatzer Cardiac PlugModerators: Vivek Reddy and Moussa Mansour |
||
|
Amplatzer Cardiac Plug Implantation: Step-By-Step Boris Schmidt |
Device Embolization – Incidence and Management Claudio Tondo |
|
Amplatzer Amulet Implantation CaseBroadcast from CardioVascular Center Frankfurt |
||
Session IV - LAA Closure Clinical OutcomesModerators: John Camm and Andre d’Avila |
||
|
Watchman Randomized Trials: 5-yr PROTECT AF, PREVAIL Vivek Reddy |
Dhanunjaya Lakkireddy |
|
|
Watchman Registry Data: CAP/CAP-2, ASAP, EWOLUTION, WASP Daniel Lustgarten |
Christopher Ellis |
|
|
Amplatzer Cardiac Plug: Single & Multicenter Registry Outcomes Thorsten Lewalter |
|
|
|
Dhanunjaya Lakkireddy, Christopher Ellis, Thorsten Lewalter, Daniel Lustgarten, |
||
Session V –Live Case and PresentationsModerator: Vivek Reddy |
||
|
Post-LAA Closure Leaks – Incidence and Management Jose Mauricio Sanchez |
ICE-Guided LAA Closure: Why? How? Vivek Reddy |
|
|
Device-Related Thrombus & Pre/Peri/Post-Implant Anticoagulation Johannes Brachmann |
|
|
Watchman Implantation – Case 2Broadcast from Mount Sinai Hospital |
||
Session VI - Other LAAC TechnologiesModerator: Miguel Valderrábano |
|
|
|
Wavecrest: Introduction & Recorded Case Tom De Potter |
LAAC Potpourri – Watchman-Flex/Lifetech/Occlutech/Aegis/Prolipsis Vivek Reddy |
|
|
Atriclip: Introduction & Recorded Case Andrea Natale |
Managing Incomplete LAA Ligation Arash Aryana |
|
|
Lariat: Introduction & Recorded Case David Wilber |
|
|
|
Tom De Potter, Andrea Natale, David Wilber, Vivek Reddy, Arash Aryana, Miguel Valderrábano |
||
Session VII – Putting it All TogetherModerators: Francis Marchlinski and Andrea Natale |
||
|
The Munich Expert Consensus Document on LAA closure Thorsten Lewalter |
Cost Effectiveness of LAA Closure Sheldon Singh |
|
Debate: Stroke Prevention in the 78 yo Diabetic Woman After Catheter Ablation for AF |
||
|
Peter Kowey |
Randall Lee |
|
|
Lucas Boersma |
Gerhard Hindricks |
|
|
Thorsten Lewalter, Sheldon Singh, Peter Kowey, Lucas Boersma, Randall Lee, |
||
Commercial Support
A special thank you to the following companies for their generous support:
Boston Scientific
Biosense Webster, Inc.
Daiichi Sankyo, Inc.
St. Jude Medical
AtriCure
SentreHEART, Inc.
Medtronic
Janssen Pharmaceuticals, Inc.
Bristol-Meyers Squibb
Sponsor
MediaSphere Medical, LLC
Faculty
Program Director |
||||
|
Vivek Reddy, MD |
||||
Faculty |
||||
|
Arash Aryana, MD Lucas Boersma, MD, PhD Johannes Brachmann, MD Tom De Potter, MD Luigi Di Biase, MD, PhD John Camm, MD Andre d’Avila, MD, PhD Shephal Doshi, MD Srinivas Dukkipati, MD Christopher Ellis, MD Michael Ezekowitz, MD Gerhard Hindricks, MD |
Jacob Koruth, MD Peter Kowey, MD Dhanunjaya Lakkireddy, MD Randall Lee, MD, PhD Thorsten Lewalter, MD Daniel Lustgarten, MD Moussa Mansour, MD Francis Marchlinski, MD Nassir Marrouche, MD Marc Miller, MD Carlos Morillo, MD Andrea Natale, MD |
Petr Neuzil, MD, PhD Jeremy Ruskin, MD Jose Mauricio Sanchez, MD Boris Schmidt, MD Horst Sievert, MD Daniel Singer, MD Sheldon Singh, MD Vijay Swarup, MD Claudio Tondo, MD, PhD Miguel Valderrábano, MD David Wilber, MD
|
||
Objectives & Target Audience
Target Audience
This activity has been developed to meet the educational needs of electrophysiologists, cardiologists, surgeons, and other physicians and associated healthcare professionals with an interest in the management of stroke in AF patients.
Learning Objectives
Upon completion of this activity, participants will be able to:
- Discuss the role of the LAA in AF-related strokes.
- Evaluate pharmacological and interventional therapeutic approaches for stroke prophylaxis in AF.
- Examine randomized clinical trial and registry data.
- Review appropriate NOACC and LAA closure patient selection criteria.
- Assess the cost-effectiveness of LAA closure therapy.
- Evaluate optimal LAA closure clinical decision making strategies and procedural approaches.
- Examine therapeutic approaches for stroke prevention post catheter ablation for paroxysmal AF.
- Review antiarrhythmic effects of LAA exclusion.
Disclaimer
This activity is designed to serve as a learning experience on evaluating optimal evidence-based treatment approaches for stroke prophylaxis in Atrial Fibrillation patients, and is not accredited for continuing medical education credits.